Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Peter Vu · SciRah

Researcher profile · Semantic Scholar

Peter Vu

Share profile

Peter Vu — researcher profile on SciRah

h-index: 7
Works: 36
Citations: 358

Most-cited papers

Disparities in telemedicine during COVID‐19
A. Qian, Melody K. Schiaffino, V. Nalawade, Lara Aziz +6 more
2022Cancer Medicine110 citations Open access
Semantic Scholar
Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies
S. Kato, R. Okamura, M. Mareboina, Suzanna Lee +10 more
2019JCO Precision Oncology60 citations Open access
Semantic Scholar
NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.
Reid M. Ness, X. Llor, M. Abbass, S. Bishu +31 more
2024The Journal of the National Comprehensive Cancer Network49 citations
Semantic Scholar
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells
G. Botta, Joseph Chao, Hong Ma, Michael E. Hahn +14 more
2024Journal for ImmunoTherapy of Cancer31 citations Open access
Semantic Scholar
Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies
Jay Jacoby, D. Mahalingam, Angela T. Alistar, E. Garmey +6 more
2025Journal for ImmunoTherapy of Cancer29 citations Open access
Semantic Scholar
Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy
Li Yu, L. Bazhenova, K. Gold, L. Tran +3 more
2021Translational Lung Cancer Research26 citations Open access
Semantic Scholar
Total Number of Alterations in Liquid Biopsies Is an Independent Predictor of Survival in Patients With Advanced Cancers
Peter Vu, Yulian Khagi, P. Riviere, A. Goodman +1 more
2020JCO Precision Oncology21 citations Open access
Semantic Scholar
Non-small cell lung cancer targetable mutations: present and future
Peter Vu, S. Patel
20207 citations
Semantic Scholar
The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma.
R. McKay, Peter Vu, L. Albiges, Xun Lin +3 more
2019Clinical Genitourinary Cancer5 citations
Semantic Scholar
Initial safety and efficacy of A2B694, a logic-gated mesothelin (MSLN)–targeted Tmod chimeric antigen receptor T-cell (CAR T) therapy in patients with advanced solid tumors with HLA-A*02 loss of heterozygosity (LOH).
J. R. Molina, J. Ward, J. R. Hecht, K. Kirtane +16 more
2026Journal of Clinical Oncology4 citations
Semantic Scholar
535 EVEREST-2: a phase 1/2 study of A2B694, a logic-gated Tmod CAR T therapy to treat solid tumors expressing mesothelin (MSLN) with HLA-A*02 loss of heterozygosity: initial safety and efficacy results
J. Ward, J. R. Hecht, K. Kirtane, Kristen Spencer +27 more
2025Regular and Young Investigator Award Abstracts4 citations Open access
Semantic Scholar
Increased Pathologic Downstaging with Induction versus Consolidation Chemotherapy in Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy—A National Cancer Database Analysis
Austin Fan, Bei-Qun Zhao, Peter Vu, Benjamin Abbadessa +4 more
2024Journal of Clinical Medicine4 citations Open access
Semantic Scholar
636 BASECAMP-1: A master prescreening study to identify patients with high-risk or metastatic solid tumors with HLA loss of heterozygosity (LOH) in preparation for Tmod CAR T-cell therapy trials
Diane M. Simeone, J. Hecht, C. Smith, Marwan G. Fakih +22 more
2023Regular and Young Investigator Award Abstracts3 citations Open access
Semantic Scholar
EVEREST-2: A seamless phase 1/2 study of A2B694, a logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with pancreatic cancer (PANC) or other mesothelin (MSLN)-expressing solid tumors and human leukocyte antigen (HLA)–A*02 loss of heterozygosity (LOH).
K. Spencer, S. Punekar, P. Grierson, Jasmine Mitchell +16 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
Silver nitrate stain masquerading as a heterotopic ossification
Peter Vu, R. Faraday, Dan Vu, Joon-Gi Kim
2020Radiology Case Reports2 citations Open access
Semantic Scholar
Results from a phase 2a study of atebimetinib in combination with mGnP in advanced or metastatic pancreatic cancer.
Vincent Chung, Peter Vu, Vincent T. Ma, N. Uboha +16 more
2026Journal of Clinical Oncology1 citations
Semantic Scholar
639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy
Diane M. Simeone, Maria Pia Morelli, J. Hecht, S. Patel +28 more
2022Regular and Young Investigator Award Abstracts1 citations Open access
Semantic Scholar
A novel NGS kit solution for multi-cancer early detection using circulating cell free DNA based methylation analysis.
Grace Q. Zhao, Yun Bao, Heng Wang, Peter Vu +2 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar
A phase 1/2 study of the next-generation nectin-4–targeting antibody-drug conjugate CRB-701 (SYS6002) in patients with recurrent or metastatic head and neck squamous cell carcinoma.
C. Mantia, Glenn J. Hanna, Y. Loriot, Peter Vu +16 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
BIO26-035: MTAP Deficiency in Thoracic Oncology: Bridging Genomic Loss, Survival Deficits, and Immunosuppressive Microenvironments.
A. Walling, Rachael Sak, S. Skootsky, N. Wenger +21 more
2026The Journal of the National Comprehensive Cancer Network0 citations
Semantic Scholar
Abstract A126: Armoring logic-gated CAR T cells with a membrane-tethered IL-12 booster: initial data from the EVEREST-2 study of A2B543 in patients with advanced pancreatic cancer
S. Punekar, J. Ward, Monica Avila, P. Grierson +28 more
2026Cancer Research0 citations
Semantic Scholar
A triage-forward outpatient diagnostic pathway for cancer evaluation: Early experiences from a Suspicion of Cancer clinic.
Tulsi Patel, Archana Ajmera, D. McLaughlin, Shelly Kane +3 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Lymphoma of the cervix invading the uterine body with distant lymphadenopathy: MRI and FDG-PET/CT findings
Isabella Vu, Peter Vu, T. Byun, Adam Stelling
2026Radiology Case Reports0 citations Open access
Semantic Scholar
Development of an analytics dashboard to measure infusion treatment initiation timelines.
Tulsi Patel, Robert Eugene Bernadelli, Adam M. Burgoyne, A. Hamdan +5 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Safety outcomes of off-unit inpatient chemotherapy and biologics administration through Chemo Without Borders, a structured certified-nurse deployment program.
Tulsi Patel, Melissa Callahan, Karen L. Armenion, S. Chau +10 more
2026JCO Oncology Practice0 citations Open access
Semantic Scholar
Evaluating Healthcare Provider and Artificial Intelligence Chatbot Responses to Patient Messages from a Health System Using the CREATE TRUST Framework.
Matthew R. Allen, V. Tiyyala, Armaan S Johal, Akhila Chekuri +16 more
2026Journal of health communication0 citations Open access
Semantic Scholar
Abstract A134: Atebimetinib Reduces Tumor Volume and Preserves Body Mass: A Dual Mechanism for Extended Survival in Pancreatic Cancer
Peter Vu, Vincent Chung, Gregory P. Botta, Daniel H. Ahn +9 more
2026Cancer Research0 citations
Semantic Scholar
Beyond national benchmarks: An EMR-integrated platform for measuring local time to treatment infusion.
Tulsi Patel, Robert Eugene Bernadelli, Shelly Kane, Adam M. Burgoyne +4 more
2026JCO Oncology Practice0 citations Open access
Semantic Scholar
Abstract 5900: Tumor-independent cfDNA methylation analysis for cancer monitoring during total neoadjuvant treatment in rectal cancer patients
Nguyen-Ta Kim, Grace Q. Zhao, Heng Wang, Teressa Celma +10 more
2025Cancer Research0 citations
Semantic Scholar
548 A Phase 1/2 study of a first-in-class non-cellular antibody-drug conjugate, micvotabart pelidotin (micvo), in combination with pembrolizumab in advanced head & neck squamous cell carcinoma (HNSCC)
G. J. Hanna, F. Johnson, D. Zandberg, G. Rabinowits +13 more
2025Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Clitoral metastasis from squamous cell carcinoma of the cervix on 18F-FDG PET/CT and MRI
R. Vu, J. Tseng, Peter Vu, Adam Stelling
2024Radiology Case Reports0 citations Open access
Semantic Scholar
Abstract 6777: An ex-vivo organotypic culture platform of mucinous carcinomatosis peritonei identifies CDK4-6 inhibition as a novel treatment
Jonathan R. Weitz, D. Nishizaki, J. Patel, Isabella Ng +13 more
2024Cancer Research0 citations
Semantic Scholar
Abstract 788: Novel multiplex methylation-specific qPCR strategy for early CRC detection
Yun Bao, Heng Wang, Peter Vu, Grace Q. Zhao +1 more
2023Cancer Research0 citations
Semantic Scholar
Efficacy and tolerability of high dose interleukin-2 (HD IL-2) after disease progression on targeted therapy (TT) for metastatic renal cell carcinoma (mRCC).
Peter Vu, Hanh P. Mai, William Adams, Beverly Gonzalez +3 more
20160 citations
Semantic Scholar
Experience with IL-2 in metastatic renal cell carcinoma after treatment with one or more targeted therapies.
Hanh P. Mai, Peter Vu, Arjun Patel, J. Clark +1 more
20160 citations
Semantic Scholar
Primary squamous cell carcinoma of the endometrium: three additional case reports with review of the literature
P. Vuong, Peter Vu, K. Rothenberger-Janzen, S. Houissa-Vuong +1 more
20010 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Maloney×6
Invite
D. Maloney — researcher profile on SciRah
M. Maus×6
Invite
M. Maus — researcher profile on SciRah
K. Kirtane×5
Invite
K. Kirtane — researcher profile on SciRah
Oliver Dorigo×5
Invite
Oliver Dorigo — researcher profile on SciRah

×5

Invite

J. Welch — researcher profile on SciRah

Invite

S. Patel — researcher profile on SciRah

Invite

J. Ward — researcher profile on SciRah

Invite

J. R. Hecht — researcher profile on SciRah

Jasmine Mitchell×4

Invite

Jasmine Mitchell — researcher profile on SciRah

Invite

S. Punekar — researcher profile on SciRah

Invite

E. Ng — researcher profile on SciRah

Invite

Shelly Kane — researcher profile on SciRah